Related Experiment Video

Updated: Jul 17, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma

Wei-Qing Xu1, Xu-Cheng Jiang, Lin Zheng

  • 1Department of Pathology, Shanghai Jiao Tong University School of Medicine, 227 South Chong Qing Rd. Shanghai, 200025, People's Republic of China.

Experimental and Molecular Pathology
|February 10, 2007
PubMed
Abstract

Insights

Colorectal carcinomas often resist transforming growth factor-beta (TGF-beta) inhibition. This study found over-expressed TGF-beta1 and reduced TbetaRII and Smad4 are linked to colorectal cancer progression and malignancy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling Pathways

Background:

  • Colorectal carcinomas frequently exhibit resistance to the growth-inhibitory effects of transforming growth factor-beta (TGF-beta).
  • This resistance is often attributed to alterations within the TGF-beta signaling pathway.
  • Understanding these molecular changes is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the expression levels of TGF-beta1, TGF-beta receptor type II (TbetaRII), and Smad4 in human colorectal carcinoma.
  • To determine the relationship between the expression of these molecules and colorectal cancer growth and progression.

Main Methods:

  • Utilized immunohistochemistry and in situ hybridization techniques.
  • Analyzed 38 cases of human colorectal carcinoma tissue samples.

Main Results:

  • High expression of TGF-beta1 protein and mRNA was observed in a majority of colorectal carcinomas.
  • A significant decrease in TbetaRII mRNA and immunoreactivity was detected in a substantial proportion of tumors.
  • Reduced expression of Smad4 protein and mRNA was prevalent, correlating with tumor differentiation, advanced Duke's stage, and lymph node metastasis.

Conclusions:

  • Over-expression of TGF-beta1 and down-regulation of TbetaRII may contribute to colorectal cancer's evasion of TGF-beta-mediated growth inhibition.
  • Reduced Smad4 expression is significantly associated with increased malignancy and progression of colorectal carcinoma.

More Related Videos

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...